These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 9526559

  • 21. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties.
    Frecer V, Berti F, Benedetti F, Miertus S.
    J Mol Graph Model; 2008 Oct; 27(3):376-87. PubMed ID: 18678515
    [Abstract] [Full Text] [Related]

  • 22. Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases.
    Stoica I, Sadiq SK, Coveney PV.
    J Am Chem Soc; 2008 Feb 27; 130(8):2639-48. PubMed ID: 18225901
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
    Ma XH, Zhang XY, Tan JJ, Chen WZ, Wang CX.
    Acta Pharmacol Sin; 2004 Jul 27; 25(7):950-8. PubMed ID: 15210071
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.
    Zhang QY, Wan J, Xu X, Yang GF, Ren YL, Liu JJ, Wang H, Guo Y.
    J Comb Chem; 2007 Jul 27; 9(1):131-8. PubMed ID: 17206841
    [Abstract] [Full Text] [Related]

  • 27. Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors.
    Li D, Liu MS, Ji B, Hwang K, Huang Y.
    J Chem Phys; 2009 Jun 07; 130(21):215102. PubMed ID: 19508101
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.
    Mor M, Rivara S, Silva C, Bordi F, Plazzi PV, Spadoni G, Diamantini G, Balsamini C, Tarzia G, Fraschini F, Lucini V, Nonno R, Stankov BM.
    J Med Chem; 1998 Sep 24; 41(20):3831-44. PubMed ID: 9748358
    [Abstract] [Full Text] [Related]

  • 32. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities.
    Ponce YM, Diaz HG, Zaldivar VR, Torrens F, Castro EA.
    Bioorg Med Chem; 2004 Oct 15; 12(20):5331-42. PubMed ID: 15388160
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Optimizing the binding of fullerene inhibitors of the HIV-1 protease through predicted increases in hydrophobic desolvation.
    Friedman SH, Ganapathi PS, Rubin Y, Kenyon GL.
    J Med Chem; 1998 Jun 18; 41(13):2424-9. PubMed ID: 9632374
    [Abstract] [Full Text] [Related]

  • 35. Three-dimensional quantitative structure: activity relationship studies on diverse structural classes of HIV-1 integrase inhibitors using CoMFA and CoMSIA.
    Nunthaboot N, Tonmunphean S, Parasuk V, Wolschann P, Kokpol S.
    Eur J Med Chem; 2006 Dec 18; 41(12):1359-72. PubMed ID: 17002889
    [Abstract] [Full Text] [Related]

  • 36. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
    Hou T, Zhang W, Case DA, Wang W.
    J Mol Biol; 2008 Feb 29; 376(4):1201-14. PubMed ID: 18206907
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prediction and analysis of binding affinities for chemically diverse HIV-1 PR inhibitors by the modified SAFE_p approach.
    Arenas M, Villaverde MC, Sussman F.
    J Comput Chem; 2009 Jun 29; 30(8):1229-40. PubMed ID: 18988271
    [Abstract] [Full Text] [Related]

  • 39. Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.
    Ali A, Reddy GS, Cao H, Anjum SG, Nalam MN, Schiffer CA, Rana TM.
    J Med Chem; 2006 Dec 14; 49(25):7342-56. PubMed ID: 17149864
    [Abstract] [Full Text] [Related]

  • 40. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS, Roy K.
    Eur J Med Chem; 2009 Apr 14; 44(4):1509-24. PubMed ID: 18760864
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.